Scientists hunt for clues to stop brain Cancer's return

NCT ID NCT07173829

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study will analyze blood and tumor samples from 45 adults with glioblastoma to understand why this aggressive brain cancer recurs. Researchers will look at molecular, immune, and metabolic changes in tumors from both new and recurrent cases. The goal is to find new targets for better treatments, not to test a specific drug.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this research could reveal new targets for future treatments for glioblastoma, a deadly brain cancer.

What could go wrong

This is an observational study, not a treatment trial. It aims to gather knowledge, not test a therapy, so direct patient benefits are unlikely in the near term.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glioblastoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••